Dyslipidemias
Conditions
Brief summary
This study seeks to improve access to lipid testing in out-of-surgery locations using PocDoc, a UKCA approved IVD device that measures a full 5 marker lipid panel using a smartphone or tablet. The study will investigate whether PocDoc can close the gap in people not tested by exploring 3 new out-of-surgery methods: 1. Lipid testing for high-risk individuals on existing CVD register who have not attended in-surgery appointments 2. Footfall lipid testing conducted in pharmacy or at community events 3. Corporate wellness lipid testing performed by employers for employees as part of an organised corporate wellness check
Detailed description
Lipid testing in out-of-surgery (OOS) locations using a digital lipid measuring device called PocDoc promises to increase access to lipid testing and cardiovascular disease health assessment. PocDoc lipids comprises a smartphone-compatible disposable microchip test strip which uses proprietary colorimetric microfluidic technology to accurately detect lipid biomarkers from a droplet of blood. PocDoc Lipids Professional was launched in 2022 to enable professional users to perform lipid screens as part of lifestyle or preventative healthcare screens. The investigator's hypothesise that providing easier, more cost-effective access to lipid testing at scale, without patients having to attend the GP surgery could: 1. Identify previously unidentified patients (including key hard to reach cohorts) who have elevated lipid levels and get them into a lipid lowering clinical pathway which reduces risk of CVD event 2. Enable increase in treat to target and move more patients from low / medium intensity statin onto high intensity, which reduces risk of CVD events 3. Identify more cases of undiagnosed FH and getting those patients into a lipid lowering pathway The SBRI 21 Phase 3 program is funding this collaborative project in partnership with SMASH PCN and AHSN NENC with the objective of increasing access to lipid testing in those geographies.
Interventions
DIAGNOSTIC_TESTPocDoc
PocDoc is a digital rapid 5-marker lipid test
Sponsors
Vital Signs Solutions Ltd
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes
Inclusion criteria
* Consent indicated from within PocDoc app * Subjects are legally competent and capable to understand character, meaning and consequences of the study * Subjects own an approved mobile device (these will be available at the time of the study on the PocDoc website and the central team will verify individuals have appropriate mobile devices before PocDoc tests are sent to them)
Exclusion criteria
* Being unable to give informed consent * \< 18 years or \> 85 years * Legally incompetent * Language barriers potentially compromising an adequate compliance with study procedures
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall response rate | Day 1 - one single test done at one timepoint | Number and proportion of individuals contacted who conduct a PocDoc test |
| Achieved response rate | Day 1 - one single test done at one timepoint | Number and proportion of individuals who conduct a PocDoc test that have dyslipidaemia |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PocDoc experience | Day 1 - one single test done at one timepoint | Number (N) and proportion (%) of individuals reporting a positive experience with the PocDoc testing pathway |
| PocDoc value | Day 1 - one single test done at one timepoint | c. Number (N) and proportion (%) of individuals reporting improvements vs in surgery testing procedure with regards to convenience, speed of testing, testing process |
Countries
United Kingdom
Outcome results
None listed